Clinical Trial Update: A Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer [Phase 1]

View source ↗

Summary

A Phase 1/1b study of ZH9 for non-muscle invasive bladder cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• ZH9 (ZH9)

Snippet

Sponsor: Prokarium Ltd | Conditions: NMIBC, High Risk NMIBC | Phase 1 | Status: ACTIVE_NOT_RECRUITING